Department of Justice Considers Lawsuit to Halt UnitedHealth’s Acquisition of Amedisys
WASHINGTON, D.C. – The U.S. Department of Justice (DOJ) is considering initiating a lawsuit to impede the acquisition of Amedisys by Optum, a subsidiary of the UnitedHealth Group, as reported by SeekingAlpha. Shares of Amedisys fell 0.6% upon hearing the news. The agreement for Optum’s acquisition of Amedisys, worth $3.3 billion or $101 per share, was made in June 2023 and is expected to be finalized this year. The DOJ commenced an investigation into potential antitrust issues relating to the Amedisys-Optum deal last summer. However, neither Amedisys nor Optum have faced any accusations of misconduct … Read more